Month: August 2021

Categories
Pharmaceutical

Wound Cleansers Constitutes the Bulk of the Antimicrobial Hydrogel Dressings, Capturing Nearly 30% of the Market Share

The global revenue Share of advance wound care was valued at US$ 10 Bn in 2019 and is poised to expand 1.4x by 2030, to reach a value pool of almost US$ 15 Bn. The high prevalence of chronic wounds has leveraged the utilization of advanced wound care products. Wound cleansers, foam dressings, and honey dressings in hospitals are boosting revenue growth of the global advance wound care market. According to IDF, diabetic ulcers have shown a rapid increase in the last decade. IDF has stated that the prevalence of diabetic ulcers is growing by 9% annually.

The COVID-19 pandemic is set to leverage market prospects for advance wound care. Since its onset, the pandemic has infected nearly six million people, resulting in over 350,000 casualties. Patients with chronic conditions such as diabetes are especially vulnerable to infection. Therefore, taking care of such patients has become top priority. Leading manufactures such as ConvaTec Group plc, have accelerated the production of hydro fibers used to treat diabetic foot ulcers.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4822

 “Greater attention towards better relationship management with surgeons could lead to higher product penetration of advance wound care product in hospitals.” says the Fact.MR Analyst.

global advance wound care market

Key Takeaways of Global Advance Wound Care Market Study

  • By product type, wound cleansers accounted for a prominent value share in the global advanced wound care market. This is primarily attributed to the growing need for wound cleansers prior to dressing.
  • North America and Europe will collectively hold 70% of the global advanced wound care market share. East Asia and South Asia are anticipated to exhibit notable CAGR, owing to growing advance wound care manufacturing facilities in these regions.
  • The hospitals segment end user dominated the global advance wound care market, attributed to high healthcare infrastructure and a large patient pool visiting hospitals.
  • U.S. represents the most lucrative market, followed by Germany for Advanced Wound Care market. While, China is expected to witness significant growth due to convenience of use and affordability of advanced wound care products.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4822

Global Advanced Wound Care Market: Segmentation

Product Type

  • Antimicrobial Gels
  • Antimicrobial Powder
  • Concentrated Surfactant
  • Hydrogels Dressings
    • Antimicrobial Hydrogel Dressings
    • Non Antimicrobial Hydrogel Dressings
  • Skin Protectants
  • Wound Cleansers
  • Semi-Permeable Films Dressings
    • Semi-Permeable Antimicrobial Films Dressings
      • Antimicrobial Bordered Film Dressings
      • Antimicrobial Non Bordered Film Dressings
    • Semi-Permeable Non Antimicrobial Films Dressings
      • Non Antimicrobial Bordered Film Dressings
      • Non Antimicrobial Non Bordered Film Dressings
  • Alginate Dressings
    • Antimicrobial Alginate Dressings
    • Non Antimicrobial Alginate Dressings
  • Foam Dressings
    • Antimicrobial Foam Dressings
      • Antimicrobial Bordered Foam Dressings
      • Antimicrobial Non Bordered Foam Dressings
    • Non Antimicrobial Foam Dressings
      • Non Antimicrobial Bordered Foam Dressings
      • Non Antimicrobial Non Bordered Foam Dressings
  • Hydrocolloid Dressings
    • Antimicrobial Hydrocolloid Dressings
    • Non Antimicrobial Hydrocolloid Dressings
  • Collagen Dressing
    • Antimicrobial Collagen Dressing
    • Non Antimicrobial Collagen Dressing
  • Contact Layer
    • Antimicrobial Wound Contact Layers
    • Non Antimicrobial Wound Contact Layers
  • Honey Dressings
  • Super Absorbent Dressings
    • Antimicrobial Super Absorbent Dressings
    • Non Antimicrobial Super Absorbent Dressings
  • Compression System
    • 2 Layer Compression System
    • 3 Layer Compression System
    • 4 Layer Compression System
  • Unna Boots
  • Tapes

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Regions

  • North America
  • Latin
  • America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4822

Following Questions Answers Covered in the Report are:

  • How will the global Advanced Wound Care Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Advanced Wound Care Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Advanced Wound Care Market?
  • How will these strategies influence the market growth and competition?

Get More Insights – https://www.biospace.com/article/increasing-demand-from-bioinformatics-end-user-segments-coupled-with-technological-developments-are-driving-uptake-of-pipetting-systems-market-projects-fact-mr/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

North America to Lead Animal Model Market the in Terms of Revenue Growth, Reveals Fact.MR Study

With the rapid developments in the healthcare industry to arrest the prevalence of chronic diseases, there is an ever-increasing need for conducting research to deliver the best medicines and drugs. This is expected to be a key growth influencer of the animal model market. Use of animal model in biomedical research has observed a rapid rise as it helps in the development of new treatment methods for new and chronic diseases, and understand the potency of drugs with regard to the pervasive diseases.

A recent report compiled by Fact.MR projects the animal model market to register an impressive CAGR of over 6.0% during the period of forecast, 2017 to 2026.

Request a report sample to gain comprehensive insights at  https://www.factmr.com/connectus/sample?flag=S&rep_id=1590

The healthcare sector is seen harnessing animal models, owing to which the demand for animal model is surging in the healthcare sector. The animal model is expected to outpace its alternatives such as tissues cultures and computer models as the living systems are pretty complex to further become a prime choice for biomedical research.

Viral epidemics such as Zika and Ebola, which have significant prevalence in regions such as Africa and Latin America, have placed a significant burden on the healthcare sector. Lack of understanding about host immune factors that control outcomes of these diseases has obstructed the development of effective treatment or vaccines. Effectiveness of animal models in developing and testing efficacy of vaccines and therapies, prior to their use in human candidates, is likely to augur well for growth of the animal models market.

North America is expected to remain the largest market for animal model with revenues anticipated to transcend over US$ 800 Mn by the end of period of forecast to account for the fastest growing market. Considering the Asia-Pacific market for animal model, it accounts for a larger revenue share compared to the market in Europe. The South Korean market, despite lowest market revenue share is expected to project higher CAGR, as compared to Latin America and Middle East & Africa (MEA) through 2026.

Among animal model species, rats and mice are expected to own over two-fifth share of the market along with revenue expansions by registering highest CAGR by the end of 2026. The largest share is contributed by Asia-Pacific region in rats market. However, dogs and pigs remain to be the least profitable species segments of the animal model market.

animal model industry 0

Between basic and applied research and drug discovery/development animal model segment, the former is expected to register fastest expansion and outgrow the latter with exceeding CAGR. However, drug discovery/development remains to be a lucrative application of the animal model.

Sensing the surging growth in the application of animal model, key market players are contributing to the same with the rising implementation of animal model in drug development and research sectors. Eurofins Scientific SE is an analytical testing services provider for evaluating the safety, composition, authenticity, and purity of biological substances and products. They have been offering animal model through their subsidiary Eurofin- Advinus Company for the research and development of compounds in pharmaceuticals, biologics, agrochemical, and cosmetics.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=1590

The company has indulged in mergers and acquisitions of laboratories and research institutes to further flourish their contribution to the growth of the animal model market. Additionally, their withstanding and strong position in the bioanalysis market gives the company a competitive edge over other market players.

The spurring need for animal models, therefore, triggers the constant strategic advancements made by these market players to outgrow amongst the rest, eventually fueling the expansion of the animal model market. Due to the continued emphasis given to biomedical research as well as the increasing application of animal model in academic and research institutions, animal modelling is sure to grow undoubtedly.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/1590/animal-model-market
Press Release: https://www.factmr.com/media-release/555/animal-model-market 
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Medical Case Management Service Market to reflect a CAGR of 3.5% over the forecast period, 2021-2026

A recent report published by Fact.MR projects the revenues from global demand for medical case management service market to reach US$ 4,138 Mn in 2017. The market is further anticipated to register a moderate expansion at 3.4% CAGR during the forecast period.

Offering highly personalized and patient-specific services, industry operators have been coordinating and planning healthcare services, which are required for assisting patients with medical rehabilitation. Owing to advantages of the medical case management services in avoiding expensive services, and neglecting services which are medically unnecessary, demand for these services has been witnessing a rise across the globe. The role of medical case management services has been expanding, focusing on medical costs, taking help from nurse case managers, and tapping into patient-centered medical homes as well as accountable care organisations.

Request a report sample to gain comprehensive insights at  https://www.factmr.com/connectus/sample?flag=S&rep_id=74

Over the past few years, the global medical case management services market has been benefitting from improving corporate profits, and increasing employment rate, resulting into the rise in number of compensation claims by workers. Majority of industry operators conduct face-to-face client visits including provider locations as well as onsite visit at hospitals. Leading providers of medical case management services are now focusing on the utilization of clinical, and analytical case screening, treatment plan adjustments, comprehensive planning, case reviews varying from physician to physician. This further helps in resolving underlying problems, promoting functional improvement, and reducing narcotic usage. These factors are expected to sustain growth of the market during the forecast period.

Leading companies in the market are shifting their focus towards enhancement of their service portfolio, by introducing cost-effective and flexible services which will strengthen their market position, and enable them to grab into untapped market share. However, high costs of medical case management services, coupled with lower number of medical insurers across developing economies may inhibit growth of the global medical case management services market.

8 Projections for the Global Medical Case Management Services Market
  1. North America will remain dominant in the global medical case management service market, accounting for the highest revenue share of the market.
  2. The medical case management service market in Asia Pacific excluding Japan (APEJ) is expected to register the fastest expansion through 2022.
  3. Telephonic medical case management services are expected to remain preferred among clients, with sales estimated to account for the largest revenues by 2022-end.
  4. Web-based services are expected to remain the second largest adopted medical case management services in the market, with sales expanding at the highest CAGR through 2022.
  5. Based on end-users, although hospitals will continue to be dominant in the global medical case management service market.
  6. Long-term disability will remain the most severe case in the global market, followed by chronic pain, and catastrophic cases. Sales of medical case management services for patients with long-term disability will account for the highest revenue share of the market.
  7. Sales of medical case management services in independent medical examinations will continue to expand at the highest CAGR through 2022.
  8. Key companies in the global medical case management service market include GENEX Services Inc., Healthcare Solutions Inc., EagleOne Case Management Solutions, Inc., EK Health Services Inc., Europ Assistance – Global Corporate Solutions, Precyse Solutions LLC., Managed Medical Review Organization Inc., Axiom Medical Consulting, LLC, and Medical Case Management Group.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=74

Focus on Long-term Disability in the Medical Case Management Service Market

The long-term disability segment represents the largest opportunity that can be tapped in the medical case management service market and is estimated to reach nearly US$ 1.5 billion by end of 2022. North America will continue to hold a significant revenue share of the market globally.

Chronic pain management closely follows long-term disability and it is also a market that needs to be targeted with customized solutions. Chronic pain management is projected to grow at a steady CAGR during the forecast period.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/74/medical-case-management-service-market
Press Release: https://www.factmr.com/media-release/63/medical-case-management-service-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Demand For Computed Tomography Image Guided Surgery Is Anticipated to Expand at a Healthy CAGR of 6.0% Over The Assessment Period

With the growing incidences of chronic conditions such as neurological disorders, cancer and other life-threatening diseases, the Demand for image guided surgery devices is set to gain traction and is anticipated to expand at a healthy CAGR of 6.0% across the forecast period (2020-2025). This growth is attributed to a burgeoning preference for minimally invasive surgical procedures which are expected to generate better clinical outcomes.

In addition, there are a growing number of partnerships between public and private entities to further research on image guided surgery devices and implement the same in different healthcare settings. Based on these trends, the global image guided surgery devices market is prophesied to accelerate and enjoy a robust growth rate. However, the onset of the COVID-19 pandemic shall hamper growth prospects, owing to deferment of elective surgical procedures in favor of addressing the immediate healthcare needs of COVID-19 patients.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4814
“The global image guided surgery devices market is poised to register positive growth, attributed to rising preference for minimally invasive surgeries over open surgery. As a result of this increased acceptance, technological innovations in image capturing have occurred. Moreover, market players are concentrating on capturing lucrative markets to maximize their revenue,” concludes a Fact.MR analyst.

Key Takeaways of Global Image Guided Surgery Devices Market Study:

  • By device type, CT scanners shall capture a major chunk of the market, amounting for more than one-fourth, while MRI devices are anticipated to account for more than 20% of the market. Ease of needle positioning and catheters shall facilitate increasing adoption of CT scanning while easy distinction between normal and malignant tissues shall drive the MRI segment.
  • By application, neurosurgeries shall dominate the market, capturing nearly 30% of the share while oncology is anticipated to surpass neurosurgeries in terms of growth, expanding at a CAGR of 7.0%. This is attributed to rising prevalence of cancers and advancements in cancer detection systems.
  • By end-user, the clinics segment shall grow the fastest, recording a 7.1% CAGR across the forecast period. Rising number of specialty clinics to perform minimally invasive procedures for detection of diseases is anticipated to steer the growth of this segment.
  • By region, North America shall retain its dominance in the market. The region shall account for more than 2/5th of the global image guided surgery devices market share. However, the Asia-Pacific is anticipated to outdo North America, expanding at a CAGR of 7.0%. Increasing population pool with chronic and infectious diseases has leveraged demand for minimally invasive procedures within Asia-Pacific.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4814

global image guided surgery devices market 2

Global Image Guided Surgery Devices Market: Segmentation

Device Type

  • Computed Tomography (CT) Scanners
  • Ultrasound Systems
  • Magnetic Resonance Imaging (MRI)
  • Endoscopes
  • X-ray Fluoroscopy
  • Position Emitted Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)

Application

  • Cardiac Surgery
  • Neurosurgery
  • Orthopedic Surgery
  • Urology
  • Gastroenterology
  • Oncology Surgery
  • Others

End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Research & Academic Institutions

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4814

COVID-19’s Impact on the Market:

The ongoing COVID-19 pandemic has generated widespread disruptions in production cycles across several business domains. Strict social distancing measures implemented by countries across the world have compelled businesses to provide remote working arrangements and shutting down of production units. With the number of cases increasing on a daily basis, the healthcare industry has been facing immense pressure regarding treatment of infected patients. As hospitals and clinics face increasing shortages of beds and essential medical equipment such as ventilators, key healthcare companies are directing all their resources in producing such equipment, resulting in partial or complete cessation of its other activities.

The global image guided surgery devices market is also anticipated to take a dip as patients are delaying their elective surgical procedures regarding chronic conditions to provide greater room for treating COVID-19 patients. In this regard, GE Healthcare is accelerating production of its CARESCAPE R860 ventilators to hospitals and clinics. This is poised to shift focus away from the production of image guided surgery devices, causing a downturn in the market.

Following Questions Answers Covered in the Report are:

  • How will the global Image Guided Surgery Devices Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Image Guided Surgery Devices Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Image Guided Surgery Devices Market?
  • How will these strategies influence the market growth and competition?

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights – https://www.biospace.com/article/demand-for-micro-bypass-systems-bolstered-by-increasing-patients-undergoing-cataract-surgery-opines-fact-mr/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Global Guided Surgery Devices Market Competition Landscape:

The global image guided surgery devices market is highly consolidated, with the top four market players accounting for over 70% market share. GE Healthcare, Medtronic, Siemens Healthineers and Koninklijke Philips N.V. are the key market players. GE Healthcare is the leader in the image guided surgery devices market, producing a range of dedicated systems for image guided surgeries such as Innova and Optima image guided surgery product series.

Medtronic accounts for the second largest share, attributed to preference of healthcare providers for its O-ARM and StealthStation product portfolio. A strong focus on organic growth strategies through expansion of business units is important for the abovementioned market players to consolidate their foothold in the market. For instance, in April 2017, GE Healthcare signed an agreement with HealthTrust to provide low energy (SPECT) and high energy (PET) radiopharmaceuticals to the latter across the U.S.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

North America to Lead Gas Chromatography Market the in Terms of Revenue Growth, Reveals Fact.MR Study

A recent research by Fact.MR estimates the global demand for gas chromatography market to exhibit an above-average expansion through the forecast period 2017 to 2022. The global market for gas chromatography is expected to exceed US$ 3,500 Mn in revenues by 2022-end.

There has been a significant surge in adoption of gas chromatography among industrial sectors such as oil & gas, agriculture, food & beverage, and healthcare. Gas chromatography is also being adopted in research organizations, academic institutes, clinical toxicology, and environmental agencies. Combination of gas chromatography and mass spectrometry (GC-MS), has found its application in fire investigation, identifying unknown samples, environmental analysis, investigation of explosives, and detection of drugs.

Request a report sample to gain comprehensive insights at  https://www.factmr.com/connectus/sample?flag=S&rep_id=193

On the back of these applications, gas chromatography will witness a substantial rise in demand in the upcoming years. Various governments are making investments for the development of advanced chromatography technologies. In addition, a number of collaborations have been witnessed between research laboratories, and academic institutes since the recent past. Gas chromatography tests have become highly imperative for drug approvals. The aforementioned factors will augment growth of the global gas chromatography market over the forecast period.

Higher growth potential for the market is being observed in emerging countries, because of their rising GDP, along with increasing healthcare spending driven by the large population base. One of the major trends discerned in the global gas chromatography market is growth in adoption of the micro gas chromatographs. A number of companies are shifting their focus to utilization of small instruments, in order to save huge investments and space. Several benefits are offered by micro gas chromatographs such as lower energy consumption, short delays in receiving results, lower sample gas quantity required, increased reliability in operation, and process accuracy & precision. However, instruments of gas chromatography involve huge initial capital investments, with shortage of skilled professions for their operation. These factors might hamper the market growth.

6 Key Projections on Future of Global Gas Chromatography Market
  1. Auto-samplers, and accessories & consumables will emerge as the fastest-selling products in the market, with auto-samplers being more lucrative than the accessories & consumables, in terms of revenues.
  2. Gas chromatography instruments will remain the most lucrative product, with sales estimated to surpass US$ 1,600 Mn in revenues by 2022-end.
  3. Oil & gas industries will continue to be the largest end-users in the global gas chromatography market. In addition, revenues from pharmaceutical & biotechnology industries, and oil & gas industries will hold approximately two-third market share during 2017 to 2022.
  4. North America will retain its dominance in the global gas chromatography market, with sales exhibiting an impressive expansion through 2022. United States is becoming well known for its biopharmaceutical research, and the production of pharmaceutical drugs. Geriatric population in North America has been surging, which in turn is driving demand for medicines to treat various diseases. These factors will propel growth of the market in North America.
  5. Europe will continue to be the second largest market for gas chromatography throughout the forecast period.
  6. Key players listed in Fact.MR’s report on the global gas chromatography market include Danaher Corporation, Perkin Elmer Inc., LECO Corporation, Shimadzu Corporation, Restek Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., DANI Instruments S.p.A, and Agilent Technologies.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=193

North America’s Dominance in the Global Gas Chromatography Market will Remain Unchallenged through 2022

North America is projected to remain the largest market for gas chromatography, expanding at an impressive CAGR through 2022. In this region, the United States is well known for biopharmaceutical research, and production of pharmaceutical drugs.

The number of geriatric population in North America is witnessing a rise, thereby driving demand for different medicines for treatment of different diseases. These factors will drive growth of gas chromatography market in North America. Europe is expected to be the second most lucrative market for gas chromatography over the forecast period.

Accessories & consumables, and auto-samplers are expected to emerge as the fastest-selling products in the global gas chromatography market. Auto-samplers will remain more lucrative than accessories & consumables of gas chromatography, in terms of revenues.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/193/gas-chromatography-market
Press Release: https://www.factmr.com/media-release/183/gas-chromatography-market 
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Urology Devices Market to reflect a CAGR of 6.4% over the forecast period, 2021-2026

Prevalence of various urological disorders has led to an upsurge in adoption of the urology devices globally. In addition, growing geriatric population is also projected to impact the global market growth of urology devices positively. Fact.MR states that the global market of urology devices is further to reflect a CAGR of 6.4% over the forecast period, 2021-2026.

Request a report sample to gain comprehensive insights at  https://www.factmr.com/connectus/sample?flag=S&rep_id=352

Factors Fuelling Global Market Growth

Growth of the global urology devices market is mainly bound to various macro-economic and micro-economic factors. Prevalence of kidney diseases will continue to fuel demand for various invasive and minimally treatment procedures. Unhygienic habits developed due to fast-paced lifestyle has led to increasing prevalence of various urological disorders among people of various age groups. Unmanaged obesity, excessive smoking and chronic coughing and sneezing has led to growing prevalence of diseases such as stress incontinence globally.

Moreover, surge in instances of childbirth and prostate surgery is further expected to contribute towards the global market growth of urology devices significantly. As childbirth surgery weakens the sphincter in women, they are more prone to urological diseases such as stress incontinence. In men, growing prevalence of prostate cancer requires a prostate gland, which could weaken the sphincter. Prevalence of diseases such as stress incontinence is further to rev up adoption of the urology devices in the healthcare industry.

urology devices market

Growing incidence of kidney stone due to lack of water intake among old age people will also continue to fuel adoption of various urological diseases. Untreated kidney stone diseases can result in other healthcare issues such as vomiting, persistent need to urinate, fever owing to infections in urinary tract. As demand for minimally treatment remains high, the healthcare professionals are significantly adopting shock wave lithotripsy devices for accurate treatment of kidney stones. Bound to these factors, the global market of urology devices is projected to witness significant growth through 2026.

In addition, manufacturers in the healthcare industry are concentrating on developing medical devices that offer minimally treatment process. Integration of leading technological developments in the medical devices enables the healthcare professionals to speed up the treatment process of the patients. The healthcare professionals are mainly adopting ultrasound or x-ray technology to trace stones in the kidney and disintegrate the stones into smaller fragments for smooth passage.

Manufacturers are further focusing on integrating advanced technology in order to develop robot-assisted medical devices. Robot-assisted medical devices are mainly tailored for accurate treatment of particular urological disorders and offer surgical navigation in order to assist during the treatment process. Increasing demand for robot-assisted urology devices and minimally treatment procedures will continue to impact the global market growth of urology devices positively throughout the forecast period.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=352

Sales to Remain High for Kidney Diseases

Prevalence of various chronic kidney disorders is projected to fuel demand for urological disorders for dialysis treatment. In terms of revenue, the dialysis devices product type segment is projected to witness the highest growth, recording more than US$ 2,100 Mn by 2026-end. In contrary, the robotic systems product type segment is projected to reflect significant CAGR over the forecast period.

By 2017-end, the hospitals and clinics end use segment is projected to generate significant revenues, accounting for more than US$ 1,500 Mn. However, the dialysis centers end use segment is projected to reflect a healthy CAGR throughout 2026. Throughout the forecast period, the cancer and BPH diseases segment is projected to reflect the fastest growth in the global market. On the other hand, the kidney disease segment is projected to witness robust revenue growth, recording more than US$ 2,400 Mn by 2026-end.

Market Players

Major players in the global market of urology devices are Baxter International, Inc., Siemens AG, Stryker Corporation, Boston Scientific Corp, Cook Medical Inc., Olympus Corporation, Richard Wolf GmbH and KARL STORZ GmbH & Co. KG.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/352/urology-devices-market
Press Release: https://www.factmr.com/media-release/341/urology-devices-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Drug Discovery Services Market worth US$ 16,800.1 Million by 2026 – Exclusive Report by Fact.MR

Drug discovery services have undergone a drastic change with the advancements in modern molecular biology methods and advanced knowledge of human genome. Drug discovery is becoming more hypothesis-driven target-based approach. Pharmaceutical companies and regulatory bodies are contributing to the drug discovery. Major pharmaceutical companies are also focusing on developing the team of excellent scientists working in many therapeutic fields and technologies.

In the recent years, there has been an increase in a number of approvals for first-in-class drugs, this reflects the impact of advanced drug discovery technologies, and approaches. Drug discovery service providers are also focusing on sequencing of the human genome in order to open the way to genomics-based methods in drug discovery.  Innovation currently seen in the drug discovery methods is based on more information about targets, disease phenotypes, and compounds.

Request a report sample to gain comprehensive insights at  https://www.factmr.com/connectus/sample?flag=S&rep_id=375

The report compiled by Fact.MR expects the global drug discovery services market is to witness robust growth, registering CAGR of 8.9% during 2017-2026. By the end of 2026, the global drug discovery services market is projected to reach US$ 16,800.1 million revenue. Increasing prevalence of chronic diseases and new diseases is driving the drug discovery services. Also, new technologies supporting drug discovery methods and techniques are evolving at a significant phase. Following are insight on how the global drug discovery services market will perform in the near future.

global drug discovery services market

6 Key Insights on Global Drug Discovery Services Market

1- North America is likely to remain dominant in the global drug discovery services market throughout the forecast period 2017-2026. Presence of leading pharmaceutical companies in the region is one of the factors driving the growth of drug discovery services in North America.

2- Asia Pacific Excluding Japan (APEJ) is also anticipated to witness significant growth during 2017-2026. India and China are slowly becoming preferred locations for drug discovery outsourcing due to the technological capabilities developed. Fewer regulations and low manufacturing costs are also fueling the growth in APEJ region.

3- Hit-To-Lead identification is likely to be the most preferred process in the global drug discovery services market. By the end of 2026, hit-to-lead identification is projected to reach nearly US$ 7,000 million revenue.

4- By drug discovery service type, medicinal chemistry is likely to witness the significant growth. Towards the end of 2026, medicinal chemistry is projected to surpass US$ 6,000 million revenue.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=375

5- Small molecules are anticipated to be the largest drug type in the global drug discovery service market. Small molecules are projected to create an incremental opportunity of more than US$ 5,800 million between 2017 and 2026.

6- On the basis of therapeutic area, highest growth is expected to be seen in oncology. Oncology is projected to reach nearly US$ 7,000 million revenue towards the end of 2026.

The report offers a profile of some prominent players in the global drug discovery services market, which will stay active through 2026. The leading companies are Thermo Fisher Scientific, Inc., Merck Millipore, GE Healthcare, Albany Molecular Research, Inc. (AMRI), Charles River Laboratories International, Evotec, Pharmaceutical Product Development, LLC. (Ppd), Covance, Jubilant Biosys, Genscript Biotech Corporation, Aurigene Discovery Technologies, Wuxi Apptec, and Syngene.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/375/drug-discovery-services-market
Press Release: https://www.factmr.com/media-release/364/drug-discovery-services-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Worldwide Sales of Medical Holographic Displays is Projected to Reach a Value Pool US$ 3.5 Bn by 2026

The Demand for medical holography is set to record impressive growth, expanding at a whopping CAGR of 34.0% during the forecast period (2020-2026).

The high adoption of holographic devices for diagnosing chronic conditions such as cardiovascular diseases and cancer, rising financial impetus from government and private organizations and a surging geriatric population pool having chronic conditions are attributed as important growth levers.

Researchers have also advocated that medical holography procedures can be effectively exploited to diagnose COVID-19 infections among asymptomatic patients. These tests are expected to provide greater accuracy over the standard RT-PCR tests. Further research is still underway in order to ascertain the viability of such tests.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4798

“Increased demand for technological advancements in imaging techniques is anticipated to leverage the market for medical holography in the forecast period. Key manufacturers are taking advantage of this fact and concentrating on broad basing their product portfolio,” concludes a Fact.MR analyst.

global medical holography market share forecast by application

Global Medical Holography Market: Segmentation

Product

  • Holographic Display
  • Holography Microscope
  • Holographic Prints
  • Holography Software

Application

  • Medical Imaging
  • Medical Education
  • Biomedical Research
  • Medical Holography Market: In-Depth Analysis on Competitive Landscape

End-User

  • Academic Centers
  • Pharmaceutical & Biotechnology Companies
  • Hospitals

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4798

global medical holography market size growth forecast

Key Takeaways of Medical Holography Market Study:

  • By product type, holographic displays are anticipated to dominate the market, capturing nearly 70% of the market share. Increasing demand for technologically enhanced devices is driving the growth of the holographic displays segment.
  • By application, biomedical research shall find the maximum application, attributed to increased applications in advanced fields such as clinical diagnostics and drug development. The segment is anticipated to capture over 60% of the medical holography market.
  • By end-user, pharmaceutical and biotechnology companies shall capture over half of the total market, due to increasing research and development being undertaken to develop advanced technologies by important market players.
  • By region, North America and Europe are anticipated to lead the medical holography market, expanding at CAGRs of 35.5% and 34.0% respectively. Increasing research and development to introduce technological advancements as well as applications in diagnosing chronic conditions are anticipated to drive market growth in both regions.

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4798

Following Questions Answers Covered in the Report are:

  • How will the global Medical Holography Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Medical Holography Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Medical Holography Market?
  • How will these strategies influence the market growth and competition?

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights – https://www.biospace.com/article/renal-artery-stenosis-treatment-demand-driven-by-rising-prevalence-of-atherosclerosis-says-fact-mr/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value ChainMedical Holography Market: Competitive Landscape:The medical holography market consists of the following market players: RealView Imaging Ltd., EchoPixel Inc., Integraf LLC, Koninklijke Philips N.V, Holoxica Ltd., HoloTech Switzerland AG, EON Reality, Inc., Lyncee Tec SA, Nanolive SA and zSpace, Inc. Out of these, the dominant market players are RealView Imaging Ltd., Koninklijke Philips N.V. and Holoxica Ltd. These players focus primarily on technological developments in order to launch new products in the market, thereby consolidating their foothold. The products offered by the dominant players include HOLOSCOPE-i Holographic Augmented Reality Medical System (RealView Imaging), the Philips interventional X-ray and ultrasound systems (Koninklijke Philips N.V) and the Interactive Holographic 3D display (Holoxica Ltd.).

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Joint Reconstruction Is Set to Expand Modestly, Registering a Moderate CAGR of 4.0% By 2026

The global demand for orthopedic devices is set to expand modestly, registering a moderate CAGR of 4.0% throughout the forecast period (2020-2026).

A rapidly expanding geriatric population pool as well as increasing incidence rates of accidents and sports injuries are major factors contributing to the growth of the global orthopedic devices market. Moreover, technological advancements such as minimally invasive surgeries, artificial intelligence, 3D-bioprinting and tissue engineering, custom-made implants and development of variable axis screw systems are anticipated to provide a significant boost to the market.

However, the coronavirus pandemic is anticipated to limit growth prospects, with patients delaying elective surgical procedures in favor of treatment for COVID-19 infected patients. However, with social distancing measures being relaxed, the market is expected to witness a gradual resurgence, attributed to the restoration of production and manufacturing capacities of key industrial players, thus ameliorating the demand-supply gap.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4780

“Rising emphasis on technological innovations is anticipated to accelerate the growth of the global orthopedic devices market. Key manufacturers are exploiting this knowledge to develop new pipeline products,” infers a Fact.MR analyst.

global orthopedic devices market 02

Global Orthopedic Devices Market: Segmentation

Product

  • Joint Reconstruction:
    • Hip Replacement:
    • Total Hip Replacement Implant
    • Partial Hip Replacement Implant
    • Hip Resurfacing Implant
    • Revision Hip Replacement Implant
  • Knee Replacement:
    • Total Knee Replacement Implant
    • Partial Knee Replacement Implant
    • Revision Knee Replacement Implant
    • Elbow & Shoulder Replacement
    • Others
  • Spinal Devices:
    • Spinal Fusion Devices
    • Spinal Non-fusion Devices
  • Trauma Fixation:
    • Metal Plates & Screws
    • Pins/Wires
    • Nails and Rods
    • Others
  • Orthopedic Prosthetics:
    • Lower Extremity Orthopedic Prosthetics
    • Upper Extremity Orthopedic Prosthetics
    • Arthroscopy Devices
  • Orthopedic Braces and Support:
    • Upper Extremity Braces and Support
    • Low Extremity Braces and Support
  • Orthopedic Accessories:
    • Bone Cement
    • Casting System
    • Removal Systems
  • Others

End-User

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical Centers
  • Others

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4780

Key Takeaways of Global Orthopedic Devices Market Study:

  • By product, the joint reconstruction segment shall dominate the market, acquiring a market share exceeding 30%. This is followed by the spinal devices segment, capturing 1/4th of the global orthopedic devices market. A large patient pool awaiting joint replacements and technological advancements in neurological surgeries are key growth drivers.
  • By end-user, orthopedic clinics are expected to gain significant traction. The segment is poised to expand 1.3x in the forecast period. However, the hospitals segment shall continue its dominance, capturing nearly half of the global orthopedic devices market.
  • By region, North America is expected to dominate the global orthopedic devices market, while Asia-Pacific shall expand the fastest. Growth in demand for orthopedic surgeries has attracted key market players to establish their businesses in North America while rising per capita healthcare expenditure is stimulating market growth in Asia-Pacific.

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4780

Following Questions Answers Covered in the Report are:

  • How will the global Orthopedic Devices Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Orthopedic Devices Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Orthopedic Devices Market?
  • How will these strategies influence the market growth and competition?

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –https://www.biospace.com/article/increasing-r-and-d-and-improved-healthcare-spending-are-key-factors-pushing-development-of-waldenstrom-macroglobulinemia-market-growth-states-fact-mr/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Robust Product Portfolio, Key to Market Players’ Strong Presence:

The global orthopedic devices market is consolidated, dominated by the following top four players: Zimmer Biomet, Johnson & Johnson, Stryker and Smith & Nephew. Collectively, these companies account for nearly 55% of the market share. Therefore, the degree of competition from new entrants is quite low. Innovations in 3D printing and personalization implants technology are anticipated to fuel the growth of emerging players in the hip implants sub-segment. Important players in the hip implants segment include Smith & Nephew, DJO Global, Inc., Wright Medical Group N.V., and Exactech, Inc.

In 2017, Zimmer Biomet Holdings dominated the hip implants sub-segment, with a strong brand image and robust product portfolio. Its products included the Taperloc Hip System, the Arcos Modular Hip System and the G7 Acetabular System. Likewise, Stryker has a robust product portfolio, offering devices in the craniomaxillofacial, foot & ankle, joint replacement, spine and trauma & extremities segments. Its brands are Allograft Bio Implants, Delta, Advanced Midface Distractor and MEDPOR TITAN 3D Orbital Floor to name a few.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Glaucoma Alpha Agonists Healthcare Industry Insights: Prostaglandins are Anticipated to Account for the Maximum Market Share

Rising prevalence of glaucoma and other visual impairments have led to an increase in the demand for therapeutic drugs to treat these conditions. Around one-tenth of the elderly population suffers from glaucoma, which is expected to increase with each passing year. Consequently, the demand for better therapy options for the treatment of glaucoma is expected to boost demand for therapeutics.

On the back of these factors, the global glaucoma therapeutics market shall witness a gradual growth, at a CAGR of 2.9% during the forecast period (2020-2026). Other generic drivers, such as a greater geriatric population pool, a rise in the diabetic population and higher healthcare spending and infrastructure shall boost market growth.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4775

“The glaucoma therapeutics market shows a positive growth trend. Its market is expected to be invigorated by continuous research and product development, especially in combination drugs. Leading market players have accordingly developed formulae which can assist in faster recovery of glaucoma patients,” concludes a Fact.MR analyst.

glaucoma therapeutics market 02

Global Glaucoma Therapeutics Market: Segmentation

Drug Class

  • Prostaglandins
  • Beta Blockers
  • Alpha Agonists
  • Carbonic Anhydrase Inhibitors
  • Combination Medications
  • Cholingerics

End-users

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4775

Key Takeaways of Global Glaucoma Therapeutics Market Study

  • Prostaglandins are anticipated to account for the maximum market share of the glaucoma therapeutics market. This is attributed to its increased adoption in first line glaucoma treatment. The drug reduces intraocular pressure (IOP) by increasing uveoscleral flow. Projections indicate a market share of more than two-fifth of the total glaucoma therapeutics market.
  • Combination medicines are becoming more prevalent for glaucoma treatment. Greater effectiveness of treatment over individual medications is a key growth driver for this segment. For example, the Rhopressa drug class, a combination formula developed by Aerie Pharmaceuticals, has been approved for usage in commercial glaucoma treatment. Projected CAGR for combination medicines is pegged at 4.7% during the forecast period.
  • Hospitals shall account for the majority of the share of glaucoma therapeutics between 2020 and 2026. Increasing number of patients coupled with the ability to provide optimum healthcare services are major growth drivers.
  • North America is set to remain a lucrative market for glaucoma therapeutics. Increased focus on research and development of therapeutic drugs and approvals of certain drug categories like Rhopressa are expected to leverage the region’s market share. Asia-Pacific is following close behind, with a projected CAGR of 3.2% during the forecast period. Introduction of new drugs like Travopost and Timolol are expected to invigorate Asia-Pacific’s market share.

Following Questions Answers Covered in the Report are:

  • How will the global Glaucoma Therapeutics Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Glaucoma Therapeutics Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Glaucoma Therapeutics Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4775

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights – https://www.biospace.com/article/emergence-of-pharma-tech-and-new-product-launches-is-driving-growth-of-global-analytical-gel-permeation-chromatography-market-notes-fact-mr/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Combination Drugs; a Growth Lever for Market Players

The global glaucoma therapeutics market consists of the following market players: Allergan plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., Santen Pharmaceuticals Co. Ltd., Valeant Pharmaceuticals, Inc. and Aerie Pharmaceuticals, Inc. Novartis AG’s Alcon division focuses on development of eye care products, such as Travatan, Simbrinza and Azarga. Allergan Plc., occupies the second position in the market, and include top selling brands like Lumigan, Alphagan, Ganfort and Combigan. More recently, the company also received an approval from the FDA to launch its DURYSTATM Biodegradable Sustained-Release Implant. This device is designed to reduce intraocular pressure in open-angle glaucoma or ocular hypertension patients.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com